Phenotyping Core
Phenotyping Core
批准号:
10579074
负责人:
GERALD I SHULMAN
金额:
$60.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2028-01-31
关键词:
CollaborationsCommunitiesDatabasesDevelopmentDiabetes MellitusDiabetic mouseExtramural ActivitiesFunctional disorderIsotopesMass FragmentographyMetabolicMetabolismMethodologyMethodsModelingMusObesityPhenotypePriceRadiolabeledResearch PersonnelServicesStandardizationTissuesawakecostempowermentgenetic manipulationin vivoinsightmetabolic phenotypemouse modelnovelnovel therapeuticsphenotypic dataprecision medicinestable isotope
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Overarching Aim of the Yale MPMOD Phenotyping Core is to provide extramural investigators access to
the unique metabolic phenotyping services provided by the Yale MPMOD at a fair and reasonable price, and
empower them to characterize the impact of their genetically manipulated mouse models of diabetes and obesity
on key metabolic parameters and whole body and tissue specific intracellular metabolic fluxes using state-of-
the-art stable and radio-labeled isotope methodology. The Specific Aims of the Yale MPMOD Phenotyping
Core are: 1) To provide the scientific community access to standardized, high quality, unique metabolic
phenotyping services currently available at the Yale MPMOD at a fair and reasonable cost, 2) To continue to
develop novel stable isotope GC-MS, LC-MS/MS and NMR methods to metabolically phenotype whole body and
intracellular metabolism in awake mice, and 3) To participate and collaborate with the National Consortium of
MPMODs and the MPMOD Coordinating Unit to maintain a national database of metabolic phenotyping data in
mouse models of obesity and diabetes. It is anticipated that the results generated by the Yale MPMOD will lead
to a better understanding of the pathophysiology of diabetes and obesity and their related metabolic
complications and lead to new therapies. Ultimately, the insights generated from in vivo metabolic phenotyping
in mouse models will facilitate the development of precision medicine approaches targeting metabolic
pathophysiology and its downstream complications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10579072
-
项目类别:
-
资助金额:$15.36万
-
财政年份:2023
-
负责人:GERALD I SHULMAN
-
依托单位:
Yale Center for Metabolic Phenotyping in Live Models of Obesity and Diabetes
-
批准号:10579071
-
项目类别:
-
资助金额:$79.56万
-
财政年份:2023
-
负责人:GERALD I SHULMAN
-
依托单位:
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
-
批准号:9894796
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2019
-
负责人:GERALD I SHULMAN
-
依托单位:
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
-
批准号:10352445
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2019
-
负责人:GERALD I SHULMAN
-
依托单位:
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1
-
批准号:10093992
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:GERALD I SHULMAN
-
依托单位:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
-
批准号:9763549
-
项目类别:
-
资助金额:$72.94万
-
财政年份:2017
-
负责人:GERALD I SHULMAN
-
依托单位:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
-
批准号:9361162
-
项目类别:
-
资助金额:$73.4万
-
财政年份:2017
-
负责人:GERALD I SHULMAN
-
依托单位:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
-
批准号:10217114
-
项目类别:
-
资助金额:$72.94万
-
财政年份:2017
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8545824
-
项目类别:
-
资助金额:$121.97万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8310171
-
项目类别:
-
资助金额:$127.1万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8150940
-
项目类别:
-
资助金额:$128.1万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8728821
-
项目类别:
-
资助金额:$125.53万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8050303
-
项目类别:
-
资助金额:$125.97万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:6948596
-
项目类别:
-
资助金额:$139.02万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:6814748
-
项目类别:
-
资助金额:$136.46万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:7285973
-
项目类别:
-
资助金额:$139.78万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:7122474
-
项目类别:
-
资助金额:$139.8万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:7493559
-
项目类别:
-
资助金额:$141.1万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Role of Mitochondrial Dysfunction in Insulin Resistance
-
批准号:6844965
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Metabolic and Physiologic Differences Between Insulin Resistant and Non-Insulin
-
批准号:7041576
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:GERALD I SHULMAN
-
依托单位:
海外基金